Citation Export
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Baek, Du San | - |
dc.contributor.author | Kim, Jeong Ho | - |
dc.contributor.author | Kim, Ye Jin | - |
dc.contributor.author | Kim, Yong Sung | - |
dc.date.issued | 2018-02-05 | - |
dc.identifier.uri | https://dspace.ajou.ac.kr/dev/handle/2018.oak/30092 | - |
dc.description.abstract | Neuropilin-1 (NRP1), which functions as a coreceptor for vascular endothelial growth factor (VEGF) and is implicated in vascular permeability and tumorigenesis, has been targeted by peptides that specifically bind to the VEGF-binding region on NRP1. Like natural VEGF ligands, all known peptides with NRP1-binding activity bind only through a carboxy (C)-terminal R/K-x-x-R/K sequence motif (x stands for any amino acids); this strict requirement is called the C-end rule (CendR). Here, we report immunoglobulin Fc-fused NRP1-specific peptides deviating from CendR. We screened a yeast surface-displayed Fc-fused non-CendR peptide library against NRP1 and isolated Fc-V12, wherein V12 peptide comprising 12 amino acids has a PPRV sequence at its C-terminal end. Although Fc-V12 lacked the CendR motif, it showed selective binding to the VEGF-binding region of NRP1 and triggered cellular internalization of NRP1, which resulted in enhanced extravasation into tumor tissues and tumor tissue penetration of the Fc-fused peptide along with the coinjected chemical drug in tumor-bearing mice. Through a saturation mutagenesis study, we identified that the Val residue at the C-terminus of Fc-V12 is crucial for NRP1 binding. We further improved NRP1 affinity of Fc-V12 (K D = ∼761 nM) through directed evolution of the upstream sequence of PPRV to obtain Fc-V12-33 (K D = ∼17.4 nM), which exhibited enhanced NRP1-mediated vascular permeability as compared with Fc-V12. Our results provide functional Fc-fused non-CendR peptides, which bind to the VEGF-binding region of NRP1 and enhance vascular permeability, expanding the sequence space of NRP1-targeting peptides. | - |
dc.description.sponsorship | This work was supported by grants from the Midcareer Researcher Program (2016R1A2A2A05005108) and the Pioneer Research Center Program (2014M3C1A3051470) from the National Research Foundation funded by the Korean government. | - |
dc.language.iso | eng | - |
dc.publisher | American Chemical Society | - |
dc.subject.mesh | Animals | - |
dc.subject.mesh | Capillary Permeability | - |
dc.subject.mesh | Carcinogenesis | - |
dc.subject.mesh | Cell Line, Tumor | - |
dc.subject.mesh | Female | - |
dc.subject.mesh | Humans | - |
dc.subject.mesh | Immunoglobulin Fc Fragments | - |
dc.subject.mesh | Ligands | - |
dc.subject.mesh | Mice | - |
dc.subject.mesh | Mice, Inbred BALB C | - |
dc.subject.mesh | Mice, Nude | - |
dc.subject.mesh | Mutagenesis | - |
dc.subject.mesh | Neoplasms | - |
dc.subject.mesh | Neuropilin-1 | - |
dc.subject.mesh | Peptides | - |
dc.subject.mesh | Protein Binding | - |
dc.subject.mesh | Recombinant Fusion Proteins | - |
dc.subject.mesh | Vascular Endothelial Growth Factor A | - |
dc.subject.mesh | Xenograft Model Antitumor Assays | - |
dc.title | Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability | - |
dc.type | Article | - |
dc.citation.endPage | 402 | - |
dc.citation.startPage | 394 | - |
dc.citation.title | Molecular Pharmaceutics | - |
dc.citation.volume | 15 | - |
dc.identifier.bibliographicCitation | Molecular Pharmaceutics, Vol.15, pp.394-402 | - |
dc.identifier.doi | 10.1021/acs.molpharmaceut.7b00761 | - |
dc.identifier.pmid | 29232521 | - |
dc.identifier.scopusid | 2-s2.0-85041651967 | - |
dc.identifier.url | http://pubs.acs.org/journal/mpohbp | - |
dc.subject.keyword | C-end rule | - |
dc.subject.keyword | neuropilin-1 | - |
dc.subject.keyword | peptide engineering | - |
dc.subject.keyword | vascular permeability | - |
dc.subject.keyword | yeast surface display | - |
dc.description.isoa | false | - |
dc.subject.subarea | Molecular Medicine | - |
dc.subject.subarea | Pharmaceutical Science | - |
dc.subject.subarea | Drug Discovery | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.